
K00135
CAS No. 869650-21-5
K00135( K-00135 | K 00135 | IMIDAZOPYRIDAZIN 1 | Imidazol[1,2-b]pyridazine 1 )
Catalog No. M27892 CAS No. 869650-21-5
K00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 264 | Get Quote |
![]() ![]() |
5MG | 404 | Get Quote |
![]() ![]() |
10MG | 593 | Get Quote |
![]() ![]() |
25MG | 888 | Get Quote |
![]() ![]() |
50MG | 1251 | Get Quote |
![]() ![]() |
100MG | 1692 | Get Quote |
![]() ![]() |
500MG | 3402 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameK00135
-
NoteResearch use only, not for human use.
-
Brief DescriptionK00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.
-
DescriptionK00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.(In Vitro):K00135 dose-dependently impairs the survival of murine Ba/F3 cells that have been rendered cytokine independent by overexpression of human PIMs. K00135 impairs survival and clonogenic growth of a panel of human acute leukemia cells. Exposure of K00135 significantly suppresses in vitro growth of leukemic blasts from five acute myelogenous leukemia patients but not of normal umbilical cord blood mononuclear cells.
-
In Vitro——
-
In Vivo——
-
SynonymsK-00135 | K 00135 | IMIDAZOPYRIDAZIN 1 | Imidazol[1,2-b]pyridazine 1
-
PathwayJAK/STAT Signaling
-
TargetPim
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number869650-21-5
-
Formula Weight306.36
-
Molecular FormulaC18H18N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC=CC(=C1)C2=CN=C3C=CC(=NN32)NCC4CC4)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Honda S, Toyota T. Photo-triggered solvent-free metamorphosis of polymeric materials. Nat Commun. 2017 Sep 11;8(1):502.
molnova catalog



related products
-
INCB053914
INCB053914 (INCB-053914) is a novel potent, and selective ATP-competitive, pan-PIM kinase inhibitor with IC50 of 0.24/30.0/0.12 nM for PIM1/2/3, respectively.
-
NMS-P645
NMS-P645 is a novel selective inhibitor of pan-Pim kinases with IC50 of 3/73/12 nM for Pim1/2/3, respectively.
-
SGI-1776
SGI-1776 is a potent, selective, orally active Pim kinase inhibitor with IC50 of 7, 363 and 69 nM for Pim1, Pim2 and Pim3, respectively.